Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bayes-Genis

Showing results (561-570 of 646) with videos related to

Pageof 65
Sort By:
Journal of the American Heart Association|May 26, 2025
Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic StudyDaina Martínez-Falguera, Júlia Aranyó, Gemma Ferrer-Curriu, et al.
The International Journal of Cardiovascular Imaging|June 4, 2020
Longitudinal strain in remote non-infarcted myocardium by tissue tracking CMR: characterization, dynamics, structural and prognostic implicationsJose Gavara, Jose F Rodriguez-Palomares, Cesar Rios-Navarro, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 31, 2024
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESCPetr Peichl, Antoni Bayes-Genis, Thomas Deneke, et al.
ESC Heart Failure|September 15, 2025
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MIFrancesco Fioretti, Javed Butler, Jacob A Udell, et al.
ESC Heart Failure|September 19, 2025
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAIMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|August 5, 2025
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESCJerremy Weerts, Otilia Țica, Julia Aranyo, et al.
European Journal of Heart Failure|May 30, 2025
Insights into the European heart failure epidemiologyPetar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
Ebiomedicine|April 19, 2020
First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graftCristina Prat-Vidal, Luciano Rodríguez-Gómez, Miriam Aylagas, et al.
European Journal of Heart Failure|May 24, 2024
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESCGiuseppe M C Rosano, Davide Stolfo, Lisa Anderson, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
Pageof 65

Showing results (561-570 of 646) with videos related to

Sort By:
Pageof 65
Journal of the American Heart Association|May 26, 2025
Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic StudyDaina Martínez-Falguera, Júlia Aranyó, Gemma Ferrer-Curriu, et al.
The International Journal of Cardiovascular Imaging|June 4, 2020
Longitudinal strain in remote non-infarcted myocardium by tissue tracking CMR: characterization, dynamics, structural and prognostic implicationsJose Gavara, Jose F Rodriguez-Palomares, Cesar Rios-Navarro, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 31, 2024
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESCPetr Peichl, Antoni Bayes-Genis, Thomas Deneke, et al.
ESC Heart Failure|September 15, 2025
Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MIFrancesco Fioretti, Javed Butler, Jacob A Udell, et al.
ESC Heart Failure|September 19, 2025
SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAIMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure|August 5, 2025
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESCJerremy Weerts, Otilia Țica, Julia Aranyo, et al.
European Journal of Heart Failure|May 30, 2025
Insights into the European heart failure epidemiologyPetar M Seferović, Marija Polovina, Gianluigi Savarese, et al.
Ebiomedicine|April 19, 2020
First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graftCristina Prat-Vidal, Luciano Rodríguez-Gómez, Miriam Aylagas, et al.
European Journal of Heart Failure|May 24, 2024
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESCGiuseppe M C Rosano, Davide Stolfo, Lisa Anderson, et al.
European Journal of Heart Failure|December 26, 2024
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trialMark C Petrie, Jacob A Udell, Stefan D Anker, et al.
Pageof 65